SCHEMBL20119451

SCHEMBL20119451

CCOC(=O)c1ccc2c(c1)CCN2I

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 4/20 0.58
SRD5A2 P31213 3/20 0.58
MAPT P10636 4/20 0.49
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CA14 Q9ULX7 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TSHR P16473 1/20 0.47
MMP13 P45452 1/20 0.47
ALDH1A1 P00352 3/20 0.46
HSD17B10 Q99714 1/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20119318 0.84 SRD5A1 (0.59) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL20178648 0.83 SRD5A1 (0.58) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL20173807 0.81 SRD5A1 (0.56) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL20119320 0.80 SRD5A1 (0.57) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL20178665 0.78 SRD5A1 (0.56) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL20173809 0.76 SRD5A1 (0.54) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL14305560 0.76 ALDH1A1 (0.58) SRD5A1SRD5A2MAPTCA12CA1
SCHEMBL19249618 0.75 CA12 (0.51) SRD5A1SRD5A2CA12CA1CA2
SCHEMBL11277835 0.75 SRD5A1 (0.58) SRD5A1SRD5A2CA12CA1CA2
SCHEMBL10443684 0.74 CA12 (0.57) SRD5A1SRD5A2MAPTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081285-A1 UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-05-03 WO disclosed